JPH04129563A - Artificial skin and its manufacture - Google Patents

Artificial skin and its manufacture

Info

Publication number
JPH04129563A
JPH04129563A JP2247300A JP24730090A JPH04129563A JP H04129563 A JPH04129563 A JP H04129563A JP 2247300 A JP2247300 A JP 2247300A JP 24730090 A JP24730090 A JP 24730090A JP H04129563 A JPH04129563 A JP H04129563A
Authority
JP
Japan
Prior art keywords
collagen
skin
film layer
denatured
heat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2247300A
Other languages
Japanese (ja)
Inventor
Mikio Koide
小出 幹夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP2247300A priority Critical patent/JPH04129563A/en
Publication of JPH04129563A publication Critical patent/JPH04129563A/en
Pending legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

PURPOSE:To decompose and absorb only a film with a body fluid such as an exudation in a cover for a burn and the like and regenerate a skin by heat- treating the collagen with a cross-link structure under the existence of water to obtain a film layer made of denatured collagen. CONSTITUTION:Collagen derived from cow corium is processed with acid or alkali, the collagen with a triple-bridge helix thus obtained is heat-treated or processed with a cross-linking agent, then it is heated at 50-125 deg.C under the existence of water to obtain a film made of denatured collagen. The telopeptide at molecule terminals is digestion-removed from the collagen processed with acid or alkali via prochtase or pepsin treatment to eliminate antigenicity for the raw material collagen. For the heat treatment, collagen is held for 24hr or longer at 110 deg.C in vacuum to be heat-dehydrated and cross-linked. When an artificial skin is to be generated, part of a patient to be grafted is peeled with a dermatome, it is divided into epidermis and corium, epidermis basal cells are put on the denatured collagen film thus obtained, fibrous bud cells are brought into contact with collagen sponge, and they are maintained under physiological conditions.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、火傷の皮膚創傷等を治療するために用いられ
る人工皮膚に関する。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to an artificial skin used for treating skin wounds such as burns.

〔従来の技術〕[Conventional technology]

人間の皮膚の重要な領域の創傷、特に重度の火傷の場合
に、その創傷を皮膚の機能の1部を備えた物質で被覆す
る必要がある。これらの機能とは流体損失の減少、感染
防止、および潜在的廠痕領域の減少を意味する。この問
題を解決するのに採られてきたアプローチは同種移植、
合成重合体構造物またはコラーゲンフィルムの使用を含
んでいる。患部に対する処理としては、本人の正常な部
位の皮膚をとり、自家移植することが現在最善の策とさ
れている。しかしながら、自家移植は常に適用可能であ
るとは限らず、例えば欠損部が広範にわたる場合などは
非常に困難なものとなり、適用可能である場合も一度に
すべての欠損部に移植することは不可能であり、長期間
にわたり幾度となく移植を繰り返す必要がある。このた
め自家移植に代わり患部を一時的にあるいは永続的に被
覆し、組繊細胞を増殖して組織の修復を促進するための
人工皮膚の開発が望まれている。
BACKGROUND OF THE INVENTION In wounds in critical areas of human skin, especially in the case of severe burns, it is necessary to cover the wound with a substance that has some of the functions of skin. These features mean reduced fluid loss, infection prevention, and reduced potential scar area. The approach that has been taken to solve this problem is allogeneic transplantation,
Including the use of synthetic polymer structures or collagen films. Currently, the best treatment for the affected area is to take skin from a normal area of the patient and perform an autologous transplant. However, autologous transplantation is not always applicable; for example, when the defect is extensive, it becomes extremely difficult, and even when it is applicable, it is impossible to transplant to all the defects at once. Therefore, it is necessary to repeat transplantation many times over a long period of time. For this reason, there is a desire to develop artificial skin that can temporarily or permanently cover the affected area in place of autologous transplants, proliferate tissue cells, and promote tissue repair.

また、近年培養移植法あるいは培養皮膚とも言える皮膚
に近い材料の移植法が行なわれてきている。これは重度
の患者を対象として、患者の残された正常部位の皮膚を
採取して、単離した細胞を試験管内で培養を行ない、も
との細胞の数十倍から数百倍に増殖したのち、被覆膜と
ともに患者の創傷部位に移植してやり、表皮化を形成さ
せ治癒を図るものである。この方法を臨床に応用した例
として、ガリコら[G、 G、 Ga1llco eL
 al、、 ]の研究にューイングランド ジャーナル
 オブメディスン、第311巻、第7号、448〜45
1頁)(New Eng、 J、 Med、+ Vol
、 3+1. Na 7 P、448〜45m984)
 )がある。
Furthermore, in recent years, a culture transplantation method or a method of transplanting a material similar to skin, which can be called cultured skin, has been carried out. This is aimed at severely ill patients, and the skin from the patient's remaining normal area is taken, and the isolated cells are cultured in a test tube, and the cells are multiplied tens to hundreds of times the size of the original cells. Later, it is transplanted together with a covering membrane to a patient's wound site to form epidermis and promote healing. As an example of clinical application of this method, Galico et al.
al., New England Journal of Medicine, Vol. 311, No. 7, 448-45.
1 page) (New Eng, J, Med, + Vol.
, 3+1. Na7P, 448-45m984)
).

〔発明が解決しようとする課題〕[Problem to be solved by the invention]

従来、生体由来材料であるコラーゲンはスポンジまたは
フィルム状に成型して創傷被覆剤として使われてきた。
Conventionally, collagen, which is a bio-derived material, has been molded into a sponge or film and used as a wound dressing.

しかし、これらで火傷等を被覆した場合、早期の組織修
復が認められないという問題があった。特に、これらの
アプローチの中における重大な問題は皮膚の置換の、特
に免疫抑制剤の存在下での拒絶や宿主の酵素による移植
片の分解である。
However, when burns and the like are covered with these, there is a problem in that early tissue repair is not observed. In particular, a significant problem within these approaches is rejection of skin replacement, especially in the presence of immunosuppressants, and degradation of the graft by host enzymes.

一方、コラーゲンの中に細胞を組み込む方法が行なわれ
ているが、培養直後のコラーゲンゲルの直径が60龍あ
ったものが、1週間経つと約10龍に収縮してしまう為
、人工皮膚として使用する場合に広範囲な熱傷に適用す
ることが難しい。
On the other hand, a method of incorporating cells into collagen has been used, but the diameter of the collagen gel immediately after culturing is 60 mm, but it shrinks to about 10 mm after a week, so it is used as artificial skin. Difficult to apply to extensive burns.

培養表皮シートを患者の創傷部位に移植する場合、主に
真皮が残存している母床に移植すると生着するが、全層
皮膚欠損側や三度熱傷の創面には生着することが難しい
。また、アテロコラーゲンシート上に表皮細胞を培養し
て移植した場合、コラーゲンシートが物質透過性が低い
為、十分な栄養供給がなされず、最終的に表皮細胞が死
滅してしまうなどの問題がある。
When a cultured epidermal sheet is transplanted to a patient's wound site, it mainly survives when transplanted to the mother bed where the dermis remains, but it is difficult to engraft on the side of a full-thickness skin defect or on the wound surface of a third-degree burn. . Furthermore, when epidermal cells are cultured and transplanted onto an atelocollagen sheet, there is a problem that, because the collagen sheet has low substance permeability, sufficient nutrients are not supplied, and the epidermal cells eventually die.

〔課題を解決するための手段〕[Means to solve the problem]

本発明は、上記事情に鑑み、移植者の表皮・線維芽細胞
を生体外で培養して、収縮することなく皮膚組織を形成
させ、火傷等の被覆において、該フィルムだけが滲出液
他の体液で分解吸収して、皮膚の再生を可能にする人工
皮膚基材を提供することを目的とする。
In view of the above circumstances, the present invention cultivates the epidermis and fibroblasts of a transplanted person in vitro to form skin tissue without shrinkage, and when covering burns, etc., only the film can absorb exudate and other body fluids. The purpose of the present invention is to provide an artificial skin base material that can be decomposed and absorbed by the skin to enable skin regeneration.

本発明の上記目的は以下の構成により達成される。The above object of the present invention is achieved by the following configuration.

1)架橋構造を有するコラーゲンを水の存在下で加熱処
理して得られる変性コラーゲンのフィルム層からなるこ
とを特徴とする人工皮膚。
1) Artificial skin comprising a film layer of denatured collagen obtained by heat-treating collagen having a crosslinked structure in the presence of water.

2)架橋構造を有するコラーゲンを水の存在下で加熱処
理して得られる変性コラーゲンのフィルム層と、その片
面に、皮膚由来の表皮細胞が重層化して形成された表皮
層とからなる人工皮膚。
2) Artificial skin consisting of a film layer of denatured collagen obtained by heat-treating collagen with a crosslinked structure in the presence of water, and an epidermal layer formed by layering skin-derived epidermal cells on one side of the film layer.

3)再構成された線維化コラーゲンフィルムを加熱処理
または架橋剤で処理し、次いでこれを水の存在下で50
〜125℃で加熱処理してコラーゲンフィルム層を調製
する工程と、かくして得られたコラーゲンフィルム層の
片面に皮膚由来の表皮細胞を接触せしめ、それを生理条
件下で維持し、前記フィルム層上で表皮細胞を増殖させ
、重層化した表皮層を前記フィルム層上に形成せしめる
工程とからなることを特徴とする第2項記載の人工皮膚
の製造方法。
3) The reconstituted fibrotic collagen film is heat treated or treated with a crosslinking agent, and then it is incubated for 50 min in the presence of water.
A step of preparing a collagen film layer by heat treatment at ~125° C., bringing skin-derived epidermal cells into contact with one side of the collagen film layer obtained in this way, maintaining it under physiological conditions, and placing it on the film layer. 3. The method for producing artificial skin according to claim 2, comprising the step of proliferating epidermal cells and forming a multilayered epidermal layer on the film layer.

4)少なくとも5重ff196の変性コラーゲンを含む
コラーゲン・変性マトリックスのスポンジ層と、その上
に積層された、架橋構造を有するコラーゲンを水の存在
下で加熱処理して得られる変性コラーゲンフィルム層と
からなる人工皮膚。
4) A collagen/denatured matrix sponge layer containing at least 5-fold FF196 denatured collagen, and a denatured collagen film layer laminated thereon obtained by heat-treating collagen having a crosslinked structure in the presence of water. Artificial skin.

5)第4項の人工皮膚の、前記変性コラーゲンフィルム
層の上面に皮膚由来の表面細胞が重層化して表皮層が形
成され、前記スポンジ層内に皮膚由来の線維等細胞の生
きている組織が形成された人工皮膚。
5) In the artificial skin of item 4, skin-derived surface cells are layered on the upper surface of the denatured collagen film layer to form an epidermal layer, and living tissues such as skin-derived fibers and other cells are present within the sponge layer. Formed artificial skin.

6)再構成された線維化コラーゲンフィルムを加熱処理
または架橋剤で処理し、次いてこれを水の存在下で50
〜125℃で加熱処理してコラーゲンフィルム層を調製
する工程と、線維化コラーゲンと変性コラーゲンの混合
物溶液を容器内に流し込み、その上に前記コラゲンフィ
ルム層をのせて凍結乾燥する工程と、前記コラーゲンフ
ィルム層には皮膚由来の表皮細胞を、前記スポンジ層に
は皮膚由来の線維等細胞をそれぞれ接触せしめ、次いで
それを生理的条件下に維持する工程とからなることを特
徴とする第5項に記載の人工皮膚の製造方法。
6) Heat-treat or treat the reconstituted fibrillated collagen film with a cross-linking agent, which is then incubated for 50 min in the presence of water.
a step of preparing a collagen film layer by heat treatment at ~125°C; a step of pouring a mixed solution of fibrotic collagen and denatured collagen into a container, placing the collagen film layer thereon and freeze-drying the collagen film layer; Item 5, characterized in that it comprises the steps of bringing skin-derived epidermal cells into contact with the film layer and skin-derived fibrous cells with the sponge layer, and then maintaining them under physiological conditions. The method for manufacturing the artificial skin described.

本発明の変性コラーゲンのフィルムは、牛真皮由来のコ
ラーゲンを酸またはアルカリ処理し、得られた二重鎖へ
ソックスを自゛するコラーゲンを加熱処理または架橋剤
で処理し、次いで水の存在下で50〜125℃で加熱す
ることによって得られる。
The denatured collagen film of the present invention is produced by treating collagen derived from bovine dermis with an acid or alkali, and then heat-treating or treating the resulting double-stranded collagen with a crosslinking agent in the presence of water. Obtained by heating at 50-125°C.

原料コラーゲンは、酸またはアルカリ処理したコラーゲ
ンを更にプロクターゼまたはペプシンにより分子末端の
テロペプチドを消化除去し、抗原性を無くしたものが好
ましい。
The raw collagen is preferably acid- or alkali-treated collagen, which is further digested with protase or pepsin to remove the telopeptide at the molecular end, thereby eliminating antigenicity.

加熱処理による場合は、コラーゲンを真空下で110℃
以上で24時間以上保持して熱脱水架橋するのが望まし
い。架橋剤で処理する場合は、架橋剤には特に制限はな
く、グルタルアルデヒドのようなアルデヒド系架橋剤、
ヘキサメチレンジイソシアネートのようなイソシアネー
ト系架橋剤、1エチル−3−(3−ジメチルアミノプロ
ピル)カルボジイミド塩酸塩のようなカルボジイミド系
架橋剤等が使用される。
In the case of heat treatment, the collagen is heated to 110°C under vacuum.
It is desirable to hold the above condition for 24 hours or more to carry out thermal dehydration crosslinking. When processing with a crosslinking agent, there are no particular restrictions on the crosslinking agent, and aldehyde crosslinking agents such as glutaraldehyde,
Isocyanate crosslinking agents such as hexamethylene diisocyanate, carbodiimide crosslinking agents such as 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride, and the like are used.

架橋が導入されるべきコラーゲンは、二重鎖へソックス
を有する分散状の水溶性のものでは架橋しても物性があ
まり向上しないので、分散状コラーゲンを37℃でりん
酸系の緩衝液を用いて中和処理し、生体内にあるような
周期性線維構造をもつ再構成された線維化コラーゲンの
形にすることが好ましい。
If the collagen to be cross-linked is a dispersed water-soluble type with socks in the double strands, the physical properties will not improve much even if cross-linked, so the dispersed collagen should be prepared at 37°C using a phosphate buffer. It is preferable to perform a neutralization treatment to form reconstituted fibrotic collagen having a periodic fibrous structure similar to that found in vivo.

架橋を導入されたコラーゲンは更に水の存在下で50〜
125℃、好ましくは90〜121’Cで20分〜1時
間加熱される。この条件下で処理したフィルムは表皮細
胞を培養している際には分解しないが、移植した場合に
は滲出液や他の体液ですみやかに分解吸収される。
The cross-linked collagen is further heated to 50-50% in the presence of water.
It is heated at 125°C, preferably 90-121'C for 20 minutes to 1 hour. Films treated under these conditions do not degrade when epidermal cells are cultured, but when transplanted, they are quickly degraded and absorbed by exudates and other body fluids.

コラーゲン・変性コラーゲンマトリックスは上記で調製
した線維化したコラーゲン溶液と変性コラーゲン溶液を
混合して、凍結乾燥して得ることができる。この際に、
スチレン容器内に混合溶液を流し込み、その上に上記の
変性コラーゲンフィルムをのせ、凍結乾燥するとフィル
ムがラミネートしたコラーゲン・変性コラーゲンのマト
リックスが得られる。
The collagen/denatured collagen matrix can be obtained by mixing the fibrotic collagen solution prepared above and the denatured collagen solution and freeze-drying the mixture. At this time,
The mixed solution is poured into a styrene container, the above-mentioned denatured collagen film is placed thereon, and the denatured collagen film is lyophilized to obtain a collagen/denatured collagen matrix laminated with the film.

人工皮膚を作製するには、まず移植すべき患者の一部を
デルマトームで剥離し、表皮と真皮に分け、更に表皮基
底細胞を上記で得られた変性コラーゲンフィルム上に、
コラーゲンスポンジには線維等細胞を接触させ、生理的
条件下で維持することによって人工皮膚が得られる。
To create artificial skin, first, the part of the patient to be transplanted is exfoliated with a dermatome, separated into the epidermis and dermis, and the epidermal basal cells are placed on the denatured collagen film obtained above.
Artificial skin can be obtained by bringing fibers and other cells into contact with the collagen sponge and maintaining it under physiological conditions.

この一連の操作は細胞を取り扱ったことのある専門家に
とっては日常的な実験のみによって行なうことができる
This series of operations can be performed by experts who have experience in handling cells using only routine experiments.

〔実 施 例〕〔Example〕

以下、実施例を示して本発明をさらに具体的に説明する
Hereinafter, the present invention will be explained in more detail with reference to Examples.

実施例 1 〈変性コラーゲンフィルムの作製〉 アテロコラーゲン1.0グラムをpH3,0の希塩酸に
溶解して、0.3(w/v)%の溶液を調整する。この
溶液を4℃の恒温槽に入れ攪拌しながら、りん酸緩衝液
を加え、終濃度が0.l(ν/V)%アテロコラーゲン
、30mMりん酸−2−すトリウム、lOhMNaCj
7であるコラーゲン溶液を調製した。次いで、37℃の
恒温槽に1日浸漬し、線維化アテロコラーゲン液を得た
。この液を遠心分M (5000r、p、a、、 10
分)して、濃縮し、0J(v/v)%線維化アテロコラ
ーゲン溶液を調製した。この溶液をスチロール容器内に
流し込み、クリーンベンチ内で風乾した。このフィルム
を真空下140℃で24時間処理して熱脱水架橋を行な
った。このフィルムを蒸留水に浸漬した状態で滅菌瓶を
用いて、121”c、30分の加熱処理を行ない、変性
コラーゲンフィルムを古だ。
Example 1 <Preparation of denatured collagen film> 1.0 g of atelocollagen is dissolved in dilute hydrochloric acid of pH 3.0 to prepare a 0.3 (w/v)% solution. This solution was placed in a constant temperature bath at 4°C, and while stirring, phosphate buffer was added until the final concentration was 0. l(v/V)% atelocollagen, 30mM 2-storium phosphate, lOhMNaCj
A collagen solution No. 7 was prepared. Next, it was immersed in a constant temperature bath at 37° C. for one day to obtain a fibrotic atelocollagen solution. This solution was centrifuged at M (5000r, p, a, 10
minutes) and concentrated to prepare a 0 J (v/v)% fibrotic atelocollagen solution. This solution was poured into a styrene container and air-dried in a clean bench. This film was treated under vacuum at 140° C. for 24 hours to perform thermal dehydration crosslinking. This film was immersed in distilled water and heated in a sterilized bottle at 121"C for 30 minutes to remove the denatured collagen film.

実施例 2 実施例1と同様に調製し、架橋を導入したフィルムを蒸
留水に浸漬し、50℃、30分の加熱処理を行ない、変
性コラーゲンフィルムを得た。
Example 2 A crosslinked film prepared in the same manner as in Example 1 was immersed in distilled water and heat-treated at 50°C for 30 minutes to obtain a denatured collagen film.

実施例 3 実施例]と同様に調製し、架橋を導入したフィルムを蒸
留水に浸漬し、70℃、30分の加熱処理を行ない変性
コラーゲンフィルムラ得り。
Example 3 A crosslinked film prepared in the same manner as in Example] was immersed in distilled water and heat-treated at 70°C for 30 minutes to obtain a denatured collagen film.

実施例 4 実施例1と同様に調製し、架橋を導入したフィルムを蒸
留水に浸漬し、90℃、30分の加熱処理を行ない変性
コラーゲンフィルムを得た。
Example 4 A crosslinked film prepared in the same manner as in Example 1 was immersed in distilled water and heat-treated at 90° C. for 30 minutes to obtain a denatured collagen film.

比較例 1 実施例1と同様に調製して、架橋を導入して加熱処理前
のフィルムを得た。
Comparative Example 1 A film was prepared in the same manner as in Example 1 to introduce crosslinking to obtain a film before heat treatment.

試験例 1 〈各種コラーゲンフィルムの特性〉 実施例1〜4および比較例1で得られたフィルムの湿潤
強度、ヘリックス含量、そして熱処理前後の面積比より
求めた収縮率を算出した。結果を表1に示す。
Test Example 1 <Characteristics of Various Collagen Films> The shrinkage rates of the films obtained in Examples 1 to 4 and Comparative Example 1 were calculated from the wet strength, helix content, and area ratio before and after heat treatment. The results are shown in Table 1.

表 温水処理温度が高い程、ヘリックス構造は破壊され変性
されていた。
The higher the surface hot water treatment temperature, the more the helical structure was destroyed and denatured.

試験例 2 くコラーゲンフィルムの酵素による分解〉上記で得られ
た各フィルムを4un1cs/mlプロテアーゼもしく
は+00units/ mlの細菌由来コラゲナーゼ溶
液中に37℃で分解させた。分解コラーゲン量は溶出し
てきたコラーゲン分解物を酸加水分解し、アミノ酸分析
によりハイドロキシプロリン含量を定量することにより
求めた。結果を第1図と第2図に示す。
Test Example 2 Degradation of collagen films by enzymes Each of the films obtained above was degraded at 37°C in a solution of 4 units/ml protease or +00 units/ml bacterial collagenase. The amount of degraded collagen was determined by acid hydrolyzing the eluted collagen degradation product and quantifying the hydroxyproline content by amino acid analysis. The results are shown in Figures 1 and 2.

図からコラーゲンフィルムは温水処理条件により酵素の
分解性が異なることがわかる。
The figure shows that the enzyme degradability of the collagen film varies depending on the hot water treatment conditions.

実施例 5 〈生きた組織の形成〉 上記で作製した変性コラーゲンフィルムを2am X 
2 cn+の大きさに切断し、これを60mmシャーレ
にフィルムを置いた。次にラット皮膚より採取した表皮
細胞を1 x 107eel Is/ mlの濃度(1
0%牛脂児血清を含むDME培地に懸濁)で1ml採取
し、更に37℃で3日間培養した。
Example 5 <Formation of living tissue> The denatured collagen film prepared above was
The film was cut into a size of 2 cn+ and placed in a 60 mm petri dish. Next, epidermal cells collected from rat skin were incubated at a concentration of 1 x 107eel Is/ml (1
1 ml of the suspension (suspended in DME medium containing 0% tallow serum) was collected and further cultured at 37°C for 3 days.

上記で細胞を採取したラットの背に2cmX2cmの欠
損創をつくり、そこに上記で得られた生きた組織を移植
した。この生きた組織が移植後1週間以内でコラーゲン
フィルムが分解して、表皮が直接母体と接っして、生着
したことが認められた。
A 2 cm x 2 cm defective wound was created on the back of the rat from which the cells were collected above, and the living tissue obtained above was transplanted thereto. It was confirmed that the collagen film of this living tissue was decomposed within one week after transplantation, and the epidermis came into direct contact with the mother's body, indicating that the tissue had survived.

実施例 6 〈変性コラーゲンをラミネートしたコラーゲン争変性コ
ラーゲンスポンジの作製〉0.3(v/v)%アテロコ
ラーゲン溶液とりん酸緩衝液(45mM  Na  H
PO4150sMNacff)を1:2の割合で混ぜ、
これを37℃で4時間インキュベートした。次にこの溶
液を500Or、p、a、でlO分遠心分離後、沈殿物
を1 (v/v)%の濃度になるように調製し、これを
上記で調製した変性コラーゲンと混合した。更にスチレ
ン製の容器に線維化コラーゲン・変性コラーゲン混合溶
液を流し込み、その上に上記で調製した変性コラーゲン
フィルムをのせ、−30℃で凍結させ、凍結乾燥を行な
い人工皮膚を得た。
Example 6 <Preparation of denatured collagen sponge laminated with denatured collagen> 0.3 (v/v)% atelocollagen solution and phosphate buffer (45mM NaH
Mix PO4150sMNacff) at a ratio of 1:2,
This was incubated at 37°C for 4 hours. Next, this solution was centrifuged at 500 Or, p, a for 10 minutes, and a precipitate was prepared to a concentration of 1 (v/v)%, and this was mixed with the denatured collagen prepared above. Furthermore, the mixed solution of fibrotic collagen and denatured collagen was poured into a styrene container, and the denatured collagen film prepared above was placed thereon, frozen at -30°C, and freeze-dried to obtain artificial skin.

実施例 7 く生きた組織の形成〉 上記で作製した変性コラーゲンフィルム・コラーゲン−
変性コラーゲンスポンジを2cmX2cmの大きさに切
断し、これを60mmシャーレに変性コラーゲンフィル
ムか下側になるように置いた。
Example 7 Formation of living tissue> Denatured collagen film/collagen produced above
The denatured collagen sponge was cut into a size of 2 cm x 2 cm and placed in a 60 mm petri dish with the denatured collagen film facing downward.

次にラット皮膚より採取した線維等細胞lXl06ee
l Is/ ml (10%牛脂児血清を含むDME培
地に懸濁した)の濃度に調製し、変性コラーゲンフィル
ム上に1ml播取した。更にスポンジのまわりに培養液
を3ml注入し、37℃で3日培養した。次にこのスポ
ンジを裏返し、変性コラーゲンフィルムか上になるよう
に置き、この上にラット皮膚より採取した表皮細胞を]
 X 107cells/mlの濃度(10%牛脂児血
清を含むDME培地に懸濁)で1ml採取し、さらに3
7℃で311間培養して所望の人工皮膚を得た。
Next, fibrous cells lXl06ee collected from rat skin
The solution was prepared at a concentration of 1 Is/ml (suspended in DME medium containing 10% tallow serum), and 1 ml was plated on a denatured collagen film. Furthermore, 3 ml of culture solution was injected around the sponge and cultured at 37°C for 3 days. Next, turn this sponge over so that the denatured collagen film is on top, and place the epidermal cells collected from rat skin on top.]
1 ml was collected at a concentration of 107 cells/ml (suspended in DME medium containing 10% tallow serum), and
The desired artificial skin was obtained by culturing at 7°C for 311 hours.

上記で細胞を採取したラットの背に2cmX2cmの欠
損創をつくり、そこに上記で得られた生きた組織を移植
した。この生きた組織は移植後すぐに生着し、移植7日
目の組織病理像では皮膚組織と同様なものが構築されつ
つあることが認められた。
A 2 cm x 2 cm defective wound was created on the back of the rat from which the cells were collected above, and the living tissue obtained above was transplanted thereto. This living tissue took root immediately after transplantation, and histopathological images on the 7th day of transplantation showed that something similar to skin tissue was being constructed.

〔発明の効果〕〔Effect of the invention〕

本発生は架橋構造を有するコラーゲンを水の存(1ミ下
で加熱処理した変性コラーゲンからなるフィルムに、皮
膚構造細胞である表皮細胞を組み込み、それらを生理的
条件下で維持することにより、生体外において生きた皮
膚組織を形成することを可能とするものである。この生
きた組織を皮膚欠損部へ移植すると、治癒過程を著しく
短縮することができる。
This development is possible by incorporating epidermal cells, which are skin structural cells, into a film made of denatured collagen that has been heat-treated in the presence of water (1 mm) and maintaining them under physiological conditions. It makes it possible to form living skin tissue outside the body.When this living tissue is transplanted into a skin defect, the healing process can be significantly shortened.

さらに本発明は変性コラーゲンフィルムと変性コラーゲ
ン・コラーゲンスポンジ層を組み合せたマトリックスに
、皮膚構成細胞である表皮細胞と線維等細胞を組み込み
、それらを生理的条件下で維持することにより、生体外
において生きた皮膚組織を形成することを可能とするも
のである。この生きた組織を皮膚欠損部へ移植するとあ
る程度組織構築がなされているため、治癒過程を著しく
短縮することができる。
Furthermore, the present invention incorporates epidermal cells and fibrous cells, which are skin constituent cells, into a matrix that combines a denatured collagen film and a denatured collagen/collagen sponge layer, and maintains them under physiological conditions to survive in vitro. This makes it possible to form a skin tissue that has a unique structure. When this living tissue is transplanted into the skin defect, some tissue has been constructed, so the healing process can be significantly shortened.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は各柾温度(50,70,90,121”c)で
温水処理したコラーゲンフィルムをプロテアーゼ溶液に
浸漬して、37℃で30分後に溶解したコラーゲン量を
示す。第2図は各種温度(50,70,90゜121℃
)で温水処理したコラーゲンフィルムをコラゲナーゼ溶
液に浸漬して、37℃で24時間後に溶解したコラーゲ
ン量を示す。 第 図 未処理 50°C 70’C 90’C +21’C 第 図
Figure 1 shows the amount of collagen dissolved after 30 minutes at 37°C after immersing a collagen film treated with warm water at various temperatures (50, 70, 90, 121"c) in a protease solution. Figure 2 shows the amount of collagen dissolved at 37°C for 30 minutes. Temperature (50, 70, 90°121°C
) The collagen film treated with warm water was immersed in a collagenase solution, and the amount of collagen dissolved after 24 hours at 37°C is shown. Figure Untreated 50°C 70'C 90'C +21'C Figure

Claims (1)

【特許請求の範囲】 1)架橋構造を有するコラーゲンを水の存在下で加熱処
理して得られる変性コラーゲンのフィルム層からなるこ
とを特徴とする人工皮膚。 2)架橋構造を有するコラーゲンを水の存在下で加熱処
理して得られる変性コラーゲンのフィルム層と、その片
面に、皮膚由来の表皮細胞が重層化して形成された表皮
層とからなる人工皮膚。 3)再構成された線維化コラーゲンフィルムを加熱処理
または架橋剤で処理し、次いでこれを水の存在下で50
〜125℃で加熱処理してコラーゲンフィルム層を調製
する工程と、かくして得られたコラーゲンフィルム層の
片面に皮膚由来の表皮細胞を接触せしめ、それを生理条
件下で維持し、前記フィルム層上で表皮細胞を増殖させ
、重層化した表皮層を前記フィルム層上に形成せしめる
工程とからなることを特徴とする請求項2に記載の人工
皮膚の製造方法。 4)少なくとも5重量%の変性コラーゲンを含むコラー
ゲン・変性マトリックスのスポンジ層と、その上に積層
された、架橋構造を有するコラーゲンを水の存在下で加
熱処理して得られる変性コラーゲンフィルム層とからな
る人工皮膚。 5)請求項4の人工皮膚の、前記変性コラーゲンフィル
ム層の上面に皮膚由来の表面細胞が重層化して表皮層が
形成され、前記スポンジ層内に皮膚由来の線維芽細胞の
生きている組織が形成された人工皮膚。 6)再構成された線維化コラーゲンフィルムを加熱処理
または架橋剤で処理し、次いでこれを水の存在下で50
〜125℃で加熱処理してコラーゲンフィルム層を調製
する工程と、線維化コラーゲンと変性コラーゲンの混合
物溶液を容器内に流し込み、その上に前記コラーゲンフ
ィルム層をのせて凍結乾燥する工程と、前記コラーゲン
フィルム層には皮膚由来の表皮細胞を、前記スポンジ層
には皮膚由来の線維芽細胞をそれぞれ接触せしめ、次い
でそれを生理的条件下に維持する工程とからなることを
特徴とする請求項5に記載の人工皮膚の製造方法。
[Scope of Claims] 1) An artificial skin comprising a film layer of denatured collagen obtained by heat-treating collagen having a crosslinked structure in the presence of water. 2) Artificial skin consisting of a film layer of denatured collagen obtained by heat-treating collagen with a crosslinked structure in the presence of water, and an epidermal layer formed by layering skin-derived epidermal cells on one side of the film layer. 3) The reconstituted fibrotic collagen film is heat treated or treated with a crosslinking agent, and then it is incubated for 50 min in the presence of water.
A step of preparing a collagen film layer by heat treatment at ~125° C., bringing skin-derived epidermal cells into contact with one side of the collagen film layer obtained in this way, maintaining it under physiological conditions, and placing it on the film layer. 3. The method for producing artificial skin according to claim 2, comprising the step of proliferating epidermal cells to form a multilayered epidermal layer on the film layer. 4) A collagen/denatured matrix sponge layer containing at least 5% by weight of denatured collagen, and a denatured collagen film layer laminated thereon obtained by heat-treating collagen having a crosslinked structure in the presence of water. Artificial skin. 5) In the artificial skin according to claim 4, skin-derived surface cells are layered on the upper surface of the denatured collagen film layer to form an epidermal layer, and living tissue of skin-derived fibroblasts is present in the sponge layer. Formed artificial skin. 6) The reconstituted fibrillated collagen film is heat treated or treated with a crosslinking agent, and then it is incubated for 50 min in the presence of water.
A step of preparing a collagen film layer by heat treatment at ~125° C., a step of pouring a mixed solution of fibrotic collagen and denatured collagen into a container, placing the collagen film layer thereon and freeze-drying it, and a step of freeze-drying the collagen film layer. 6. The method according to claim 5, comprising the steps of bringing skin-derived epidermal cells into contact with the film layer and skin-derived fibroblasts with the sponge layer, and then maintaining them under physiological conditions. The method for manufacturing the artificial skin described.
JP2247300A 1990-09-19 1990-09-19 Artificial skin and its manufacture Pending JPH04129563A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2247300A JPH04129563A (en) 1990-09-19 1990-09-19 Artificial skin and its manufacture

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2247300A JPH04129563A (en) 1990-09-19 1990-09-19 Artificial skin and its manufacture

Publications (1)

Publication Number Publication Date
JPH04129563A true JPH04129563A (en) 1992-04-30

Family

ID=17161375

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2247300A Pending JPH04129563A (en) 1990-09-19 1990-09-19 Artificial skin and its manufacture

Country Status (1)

Country Link
JP (1) JPH04129563A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05504085A (en) * 1990-10-02 1993-07-01 イムデックス ソシエテ アノニム Collagen-based biological materials and their uses
JP2002526207A (en) * 1998-09-18 2002-08-20 イムデ ビオマテリオー Double composite collagenous material, its acquisition method and therapeutic application
JP2012213390A (en) * 2011-03-28 2012-11-08 Tokyo Metropolitan Industrial Technology Research Institute Collagen gel membrane and cultivation vessel
CN104436312A (en) * 2014-11-12 2015-03-25 江苏德威兰医疗器械有限公司 Artificial skin prepared by collagen and polymer material through ultrasonic treatment

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05504085A (en) * 1990-10-02 1993-07-01 イムデックス ソシエテ アノニム Collagen-based biological materials and their uses
JP2002526207A (en) * 1998-09-18 2002-08-20 イムデ ビオマテリオー Double composite collagenous material, its acquisition method and therapeutic application
JP2012213390A (en) * 2011-03-28 2012-11-08 Tokyo Metropolitan Industrial Technology Research Institute Collagen gel membrane and cultivation vessel
CN104436312A (en) * 2014-11-12 2015-03-25 江苏德威兰医疗器械有限公司 Artificial skin prepared by collagen and polymer material through ultrasonic treatment

Similar Documents

Publication Publication Date Title
EP0403650B1 (en) Medical material permitting cells to enter thereinto and artificial skin
US5350583A (en) Cell-penetrable medical material and artificial skin
JP2820796B2 (en) Biotherapeutic cell-coated microspheres
JP2834155B2 (en) Collagen flake body
CN101361990B (en) Double layer artificial skin and preparation method thereof
US6699287B2 (en) Dermal scaffold using alkaline pre-treated chitosan matrix or alkaline pre-treated chitosan and alkaline pre-treated collagen mixed matrix
JPH05506169A (en) Synthetic biological skin equivalent
JPH11503946A (en) Artificial skin containing a biocompatible substance based on a hyaluronic acid derivative as a support
CN101361989A (en) Double membrane tissue patching material and preparation method thereof
CN101773687B (en) Preparation method of composite soft-tissue patch
JP2003525083A (en) Wound healing agent
JP2010504122A (en) Synthetic multilayer structure comprising biopolymer fibers
EP1115432B2 (en) Dermal scaffold using neutralized chitosan sponge or neutralized chitosan/collagen mixed sponge
CN104771787A (en) Composite support containing PGA strengthening net, preparation method and applications thereof
KR102493436B1 (en) Development of dermal layer with shrinkage control, and preparation of artificial skin with uniform performance
JPH1147258A (en) Medical base material containing gelatin and collagen
Vaienti et al. Limb trauma: the use of an advanced wound care device in the treatment of full-thickness wounds
CN102172337B (en) Tissue engineering skin with sebaceous gland-like structure and preparation method thereof
EP0411124B1 (en) Medical material permitting cells to enter thereinto and artificial skin
US5300306A (en) Tissue-equivalent membrane from bovine esophageal tissue
JPH04129563A (en) Artificial skin and its manufacture
JPH05184661A (en) Artificial skin
JP3105308B2 (en) Artificial skin and method for producing the same
KR100644078B1 (en) Dermal substitute consisting of amnion and biodegradable polymer, the preparation method and the use thereof
JPH0271749A (en) Artificial skin